Until joining the company a few years ago, J&J neuroscience R&D head Husseini Manji led the mood and anxiety disorders program at the National Institutes of Health.

Johnson & Johnson, the world's biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017.

(The follicularly-challenged central banker must truly be tearing his hair out right about now, for Rogaine maker Johnson & Johnson (JNJ) has just been assigned a �Sell� rating.) Thus in the space of one spacy session, investors learned the age-old ...

We have checkups for our bodies, our teeth, and even our cars. Why not do the same for our stocks? With that in mind, here is an inaugural monthly checkup for Johnson & Johnson (NYSE: JNJ ) stock. Let's look at three key areas to find out J&J's stock ...

In response to a staggering decline in sales and a recent U.S. Food and Drug Administration (FDA) proposal to tighten regulations on all-metal hip implants, Johnson & Johnson has opted to halt the sale of its metal-on-metal products. DePuy Orthopaedics ...

The panelists will include: Steve Bleiberg, Johnson & Johnson Technology manager in IT shared Services, Chris Bottger, IVCi Senior Vice President-Collaboration Services and Tim Reik, AVI-SPL Senior Vice President of Services Operations.

Today, we'll dive deeper into health care and consumer products giant Johnson & Johnson (NYSE: JNJ ) . Owning Johnson & Johnson stock as a dividend play makes all kinds of sense, because the company scores better than the Dow Jones Industrial ...

NEW BRUNSWICK, N.J., May 23, 2013 /PRNewswire via COMTEX/ -- At a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced they anticipate submitting more than 10 ...

The source also said since the disposal of Johnson & Johnson's pharmaceutical segment will be treated as local assets sale, the company will retain its legal entity in Pakistan and continue with its FMCG and medical devices and diagnostics business.

�For all you love, Johnson & Johnson Johnson & Johnson.� So ends the new TV spot from TBWA LA for Johnson & Johnson, advertising not the company's baby shampoo or Band-Aids, per se, but the company itself. Johnson & Johnson today introduced its ...